Trial intelligence / Profile preview

Sildenafil with Pulmonary Rehabilitation in COPD-PH

NCT01055405Phase 4Completed

Sponsor
Hospital Clínic de Barcelona
Start
Aug 2008
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ASP-001 in pulmonary hypertension (PH) (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Endurance time in constant work exercise test (CWET) at 3 months. Started Aug 2008; status: completed.

02

Drugs

ASP-001
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT01055405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01055405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call